How many insider declarations has LoPriore Vincent S filed?

LoPriore Vincent S has filed 2 public insider declarations with SEC (Form 4).

What is LoPriore Vincent S's role?

LoPriore Vincent S's reported role is not specified by the regulator across the filings.

Which companies does LoPriore Vincent S report trades for?

LoPriore Vincent S reports trades for Hepion Pharmaceuticals, Inc..

What is LoPriore Vincent S's declared buy vs sell volume?

Across the available history, declared buys total 213k€ and disposals 0.

← Executives ★ Sign in to follow

LV

LoPriore Vincent S

CHAIRMANM

·SEC (Form 4)

Hepion Pharmaceuticals, Inc.

0

申报总数

0

公司

€212,870

▲ 买入（2 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

2

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

Explore the complete record of transactions filed by LoPriore Vincent S. Insider active across 1 company, notably Hepion Pharmaceuticals, Inc.. In total, 2 reports have been recorded. Split: 2 buys · 0 sell. Total volume traded: €213k. Activity tracked since 21 April 2026. The latest transaction was disclosed on 21 April 2026 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.

Companies and markets linked to LoPriore Vincent S

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Hepion Pharmaceuticals, Inc. (US)

申报2 总计

▲

LoPriore Vincent S

Executive Chairman高管2026年4月21日Hepion Pharmaceuticals, Inc.

US$200,000强 · 72SEC ↗

5,000,000 股@ US$0.0410.76% mcap80.0% 占其流量Common Stock, par value $0.0001 per shareSEC:0001493152-26-019029:0

标准退出：2026年7月20日 (T+90)

▲

LoPriore Vincent S

Executive Chairman高管2026年4月21日Hepion Pharmaceuticals, Inc.

US$50,00064SEC ↗

1,250,000 股@ US$0.042.69% mcap20.0% 占其流量Common Stock, par value $0.0001 per shareSEC:0001493152-26-019029:1

标准退出：2026年7月20日 (T+90)

2 条申报中的 2 条

InsidersTradesSigma

← Executives ★ Sign in to follow

LV

LoPriore Vincent S

CHAIRMANM

·SEC (Form 4)

Hepion Pharmaceuticals, Inc.

0

申报总数

0

公司

€212,870

▲ 买入（2 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

2

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

Explore the complete record of transactions filed by LoPriore Vincent S. Insider active across 1 company, notably Hepion Pharmaceuticals, Inc.. In total, 2 reports have been recorded. Split: 2 buys · 0 sell. Total volume traded: €213k. Activity tracked since 21 April 2026. The latest transaction was disclosed on 21 April 2026 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.

Companies and markets linked to LoPriore Vincent S

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Hepion Pharmaceuticals, Inc. (US)

申报2 总计

▲

LoPriore Vincent S

Executive Chairman高管2026年4月21日Hepion Pharmaceuticals, Inc.

US$200,000强 · 72SEC ↗

5,000,000 股@ US$0.0410.76% mcap80.0% 占其流量Common Stock, par value $0.0001 per shareSEC:0001493152-26-019029:0

标准退出：2026年7月20日 (T+90)

▲

LoPriore Vincent S

Executive Chairman高管2026年4月21日Hepion Pharmaceuticals, Inc.

US$50,00064SEC ↗

1,250,000 股@ US$0.042.69% mcap20.0% 占其流量Common Stock, par value $0.0001 per shareSEC:0001493152-26-019029:1

标准退出：2026年7月20日 (T+90)

2 条申报中的 2 条

LoPriore Vincent S

内部人交易记录

Companies and markets linked to LoPriore Vincent S

Related entities

LoPriore Vincent S

内部人交易记录

Companies and markets linked to LoPriore Vincent S

Related entities